Depomed Inc., of Newark, Calif., confirmed that Horizon Pharma plc, of Dublin, said it commenced an unsolicited exchange offer to acquire all outstanding shares of Depomed, offering an exchange ratio of 0.95 of Horizon shares for each share of Depomed.